Pronóstico del mercado de marihuana medicinal de América del Norte hasta 2028 – Impacto de COVID-19 y análisis regional – por tipo de producto (forma seca y forma de extracto), aplicación (manejo del dolor, síndrome de Tourette, enfermedad de Alzheimer, migrañas, depresión y ansiedad, Esclerosis Múltiple, Cáncer y Otros) y Canal de Distribución (Farmacia Minorista, Comercio Electrónico y Otros)

Se espera que el mercado de marihuana medicinal de América del Norte crezca de 7.170,17 millones de dólares en 2022 a 20.760,41 millones de dólares en 2028. Se estima que registrará una tasa compuesta anual del 19,4% entre 2022 y 2028. ;

El aumento de las aprobaciones de productos de marihuana medicinal impulsa el crecimiento del mercado de marihuana medicinal en América del Norte

< p>El potencial medicinal de la marihuana ha atraído a varios investigadores y empresas a utilizar la marihuana en aplicaciones médicas. Por ejemplo, el tetrahidrocannabinol (THC) se utiliza principalmente para producir medicamentos. La Administración de Alimentos y Medicamentos de EE. UU. (FDA) ha aprobado medicamentos a base de THC como Cesamet, que contiene nabolina como ingrediente activo, es un producto derivado sintéticamente que tiene una estructura similar al THC. Cesamet se prescribe para el tratamiento de las náuseas en pacientes que reciben quimioterapia. Cesamet generalmente se prescribe cuando otros medicamentos no pueden controlar las náuseas y los vómitos. La FDA también aprobó Marinol y Syndros para usos terapéuticos en Estados Unidos. Marinol y Syndros contienen el ingrediente activo dronabinol, un 9-THC sintético considerado el componente psicoactivo del cannabis. Los medicamentos Marinol y Syndros se recetan para estimular el apetito en pacientes con síndrome de emaciación, desarrollado como una de las indicaciones del SIDA. De manera similar, se han aprobado o se encuentran en ensayos clínicos varios productos a base de marihuana. Por ejemplo, nabiximols (Sativex) es un fármaco aprobado que se comercializa en Canadá. Nabiximols es un extracto de cannabis que se utiliza para tratar la espasticidad y el dolor neuropático relacionado con la esclerosis múltiple. Está formulado con una combinación de THC y otro cannabidiol (CBD). En febrero de 2020, CanaQuest Medical Corp, una empresa canadiense, solicitó la aprobación de la producción y comercialización de Mentabinol a Health Canada. El mentabinol es un producto a base de THC y su solicitud de aprobación se presentó conforme a la Ley del Cannabis. El aumento en la aprobación de los productos a base de marihuana mencionados anteriormente por parte de la FDA está impulsando el mercado de la marihuana medicinal.

Descripción general del mercado de marihuana medicinal en América del Norte

El mercado de marihuana medicinal de América del Norte está segmentado en EE. UU., Canadá y México. Se estima que el mercado de la marihuana medicinal tiene la mayor participación en Estados Unidos. El crecimiento del mercado de la marihuana medicinal se puede atribuir a la creciente investigación y colaboraciones para explorar aplicaciones terapéuticas innovadoras, la mayor conciencia sobre la marihuana medicinal y la presencia de actores clave en la región. Además, el creciente envejecimiento de la población en toda la región también favorecerá el crecimiento del mercado.

Ingresos y pronóstico del mercado de marihuana medicinal de América del Norte hasta 2028 (EE. UU. millones de dólares)

Mercado de marihuana medicinal en América del Norte Segmentación

El mercado de marihuana medicinal de América del Norte está segmentado por tipo de producto, aplicación, canal de distribución y país.

Según el tipo de producto, el mercado de marihuana medicinal de América del Norte se segmenta en forma seca y en forma de extracto. El segmento de forma de extracto ocupó una mayor participación del mercado de marihuana medicinal de América del Norte en 2022.

Según la aplicación, el mercado de marihuana medicinal de América del Norte se segmenta en manejo del dolor, Tourette, enfermedad de Alzheimer, migrañas, depresión y ansiedad, esclerosis múltiple, cáncer y otros. El segmento de tratamiento del dolor tuvo la mayor participación del mercado de marihuana medicinal de América del Norte en 2022.

Según el canal de distribución, el mercado de marihuana medicinal de América del Norte se segmenta en farmacia minorista, e -comercio, y otros. El segmento de farmacia minorista tuvo la mayor participación del mercado de marihuana medicinal de América del Norte en 2022.

Según el país, el mercado de marihuana medicinal de América del Norte está segmentado en EE. UU., Canadá, y México. Estados Unidos dominó el mercado de marihuana medicinal de América del Norte en 2022.

Aphria, Inc.; Corporación Médica CanaQuest; Corporación de Crecimiento de Canopy; Esmeralda Salud Therapeutics Inc.; Productos farmacéuticos GW; MARICANN INC.; Organigrama Holdings Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; y VIVO Cannabis Inc son las empresas líderes que operan en el mercado de marihuana medicinal de América del Norte.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Medical Marijuana Market – by Product

1.3.2 North America Medical Marijuana Market – by Application

1.3.3 North America Medical Marijuana Market – by Distribution Channel

1.3.4 North America Medical Marijuana Market – by Country

2. North America Medical Marijuana Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Medical Marijuana Market – Market Landscape

4.1 Overview

4.2 North America – PEST Analysis

4.3 Expert Opinion

5. North America Medical Marijuana Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Approvals of Medical Marijuana Products

5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America

5.2 Market Restraints

5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana

5.3 Market Opportunities

5.3.1 Increase in Job Opportunities in Marijuana Industry

5.4 Future Trends

5.4.1 Widespread Distribution of Medical Marijuana

5.5 Impact Analysis

6. Medical Marijuana Market – North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

7.3 Dried Form

7.3.1 Overview

7.3.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Extract Form

7.4.1 Overview

7.4.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis – by Application

8.1 Overview

8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

8.3 Pain Management

8.3.1 Overview

8.3.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Tourette’s

8.4.1 Overview

8.4.2 Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Alzheimer’s Disease

8.5.1 Overview

8.5.2 Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Migraines

8.6.1 Overview

8.6.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Depression and Anxiety

8.7.1 Overview

8.7.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Multiple Sclerosis

8.8.1 Overview

8.8.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Cancer

8.9.1 Overview

8.9.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market – by Distribution Channel

9.1 Overview

9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

9.3 Retail Pharmacy

9.3.1 Overview

9.3.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.4 E-Commerce

9.4.1 Overview

9.4.2 E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2 US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2 Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2 Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Medical Marijuana Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Panaxia Pharmaceutical Industries Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Phoena Holdings Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Emerald Health Therapeutics Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 MARICANN INC.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Aphria, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Canopy Growth Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CanaQuest Medical Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 GW Pharmaceuticals

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Organigram Holdings Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for North America Medical Marijuana Market

LIST OF TABLES

Table 1. US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 3. US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 6. Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 9. Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10. Organic Developments in the Medical Marijuana Market

Table 11. Inorganic Developments in the Medical Marijuana Market

Table 12. Glossary of Terms for North America Medical Marijuana Market

LIST OF FIGURES

Figure 1. North America Medical Marijuana Market Segmentation

Figure 2. North America Medical Marijuana Market, By Country

Figure 3. North America Medical Marijuana Market Overview

Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market

Figure 5. US to Show Remarkable Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

Figure 9. Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

Figure 12. Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

Figure 21. Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

Figure 26. US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000